ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
43 announcements with these filters
HealthCare Global Enterprises filed its Annual Secretarial Compliance Report for FY 2025-26. The auditor confirmed adherence to SEBI regulations with no adverse observations reported.
HCG delivered strong FY26 results with 15% revenue growth and margin expansion to 18.5%, driven by operational leverage and clinical excellence.
HealthCare Global Enterprises confirmed zero deviation in utilizing ₹424.68 Crore raised through its recent Rights Issue. The funds were deployed for debt repayment and acquisitions.
HealthCare Global reported FY26 revenues of ₹2,545.4 Crore, a 15% year-on-year increase. Adjusted EBITDA grew 19%, reflecting strong oncology network performance and improved capacity utilization.
HCG reported FY26 revenue of INR 25.4bn (up 15% YoY) and Adj. EBITDA of INR 4.7bn (up 19% YoY), driven by network productivity and operational leverage.
HealthCare Global Enterprises appointed Sanjeev Kumar as CFO and re-appointed Rajiv Maliwal as Independent Director. These leadership updates take effect from May 2026.
HealthCare Global Enterprises is divesting its entire stake in BACC Health Care for ₹37.64 Crore. The sale to Inviga Healthcare Fund I enables strategic cancer-care focus.
Healthcare Global Enterprises Ltd reported revenue from operations of ₹650.3 Cr (+11.5% YoY) and net profit of ₹4 Cr (-41.2% YoY) for Q4 FY26.
HealthCare Global approved FY2026 audited results and the ₹37.64 Crore divestment of its BACC subsidiary. The company also appointed a new CFO and Internal Auditor.
HealthCare Global launched a new 132-bed comprehensive cancer hospital in Hebbal, North Bengaluru. The facility introduces Karnataka's first MR-Linac technology for precision oncology.
Healthcare Global Enterprises Limited filed its monitoring agency report for the ₹424.68 Crore rights issue. Proceeds remain unutilized as of the March 2026 quarter end.
HealthCare Global Enterprises Limited has scheduled a Board Meeting on May 19, 2026, to approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The trading window remains closed until 48 hours after the declaration of results.
Healthcare Global Enterprises Limited has completed the acquisition of an additional 34% stake in Vizag Hospital for ₹154.50 Crore. This transaction increases the Company's total ownership to 85% equity share capital. The acquisition was executed pursuant to a Share Purchase Agreement with the selling shareholders.